ELABELA/APELA Levels Are Not Decreased in the Maternal Circulation or Placenta among Women with Preeclampsia
Open Access
- 1 August 2018
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 188 (8) , 1749-1753
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (1062418, 1136418, 1150828)
This publication has 22 references indexed in Scilit:
- Differential activation of placental unfolded protein response pathways implies heterogeneity in causation of early‐ and late‐onset pre‐eclampsiaThe Journal of Pathology, 2014
- ELABELA: A Hormone Essential for Heart Development Signals via the Apelin ReceptorDevelopmental Cell, 2013
- Hypertension in PregnancyObstetrics & Gynecology, 2013
- TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusionsGenome Biology, 2013
- Perinatal Outcomes in Large Infants Using Customised Birthweight Centiles and Conventional Measures of High BirthweightPaediatric and Perinatal Epidemiology, 2012
- Preeclampsia, a Disease of the Maternal EndotheliumCirculation, 2011
- Cutadapt removes adapter sequences from high-throughput sequencing readsEMBnet.Journal, 2011
- Soluble FLT1 sensitizes endothelial cells to inflammatory cytokines by antagonizing VEGF receptor-mediated signallingCardiovascular Research, 2010
- Soluble endoglin contributes to the pathogenesis of preeclampsiaNature Medicine, 2006
- Preeclampsia: An endothelial cell disorderAmerican Journal of Obstetrics and Gynecology, 1989